Scientists warn that an ancient killer is becoming more resistant to antibiotics

Scientists warn that an ancient killer is becoming more resistant to antibiotics ...

Typhoid fever might be rare in developed countries, but this ancient danger, which is thought to have existed for centuries, is still a threat in our modern world.

According to new research, the bacterium that causes typhoid fever is transforming extensive medication resistance, and it is rapidly substituting strains that aren''t resistant.

Currently, antibiotics are the only methods to effectively treat typhoid, which is caused by the bacterium Salmonella enterica serovar Typhi. Yet over the past three decades, the bacterium''s resistance to oral antibiotics has increased and spread.

Researchers discovered a recent increase in extensively drug-resistant Typhi while sequencing the genomes of 3,489 S Typhi strains that contracted from 2014 to 2019.

Typhi, which is non-violent to frontline antibiotics, like ampicillin, chloramphenicol, and trimethoprim/sulfamethoxazole, is growing resistant to newer antibiotics, including fluoroquinolones and third-generation cephalosporins.

These strains are equating in speed worldwide.

While the majority of XDR Typhi cases originated from South Asia, researchers have identified over 200 cases of international spread since 1990.

Most strains have been shipped to Southeast Asia, as well as East and Southern Africa, but typhoid superbugs have been discovered in the United Kingdom, the United States, and Canada.

"The rapidity at which extremely-resistant strains of S. Typhi have developed and spread in recent years is a real source of concern, and highlights the need to urgently expand prevention initiatives, particularly in countries at high risk," says Stanford University economist Jason Andrews.

Scientists have been warning about the drug-resistant typhoid for years now, but the new research is the most comprehensive genome investigation on the bacterium to date.

In 2016, the first XDR typhoid strain was discovered in Pakistan. By 2019, it became the dominant genotype in the country.

Most XDR typhoide strains have been fought with third-generation antimicrobials, like quinolones, cephalosporins, and macrolides.

In Bangladesh, India, Pakistan, Nepal, and Singapore, mutations that confer resistance to quinolones accounted for over 85 percent of all cases. At the same time, cephalosporin resistance sat in the early 2000s.

There is only one oral antibiotic left: the macrolide and azithromycin. This medicine may not be used for much longer.

Mutations that confer resistance to azithromycin are now expanding, "bedastating the effectiveness of all oral antimicrobials for typhoid treatment," according to the XDR S Typhi. If these mutations are, we are in serious danger.

Up to 20 percent of typhoid cases are fatal if untreated, and today, there are 11 million cases of typhoid per year.

Future infections may be facilitated in some ways by typhoide conjugate vaccinations, but if access to these medications is not expanded globally, the world might soon face another health issue.

"The development of XDR and azithromycin-resistant S Typhi has given an increased need for rapid improvement in prevention measures, including the use of typhoid conjugate vaccinations in typhoid-endemic countries," states the authors.

"Such measures are required in countries where antimicrobial resistance prevalence among S Typhi isolates is currently high, but given the propensity for international spread, they should not be restricted to such settings."

South Asia might be the leading cause of typhoid fever, accounting for 70 percent of all cases, but if COVID-19 has taught us anything, it is possible that diseases variations in our modern, globalized world are widespread.

Health experts argue that nations should increase access to typhoid vaccinations and invest in more antibiotic research. One recent study in India, for example, found that if children are vaccinated against typhoid in urban areas, it might prevent up to 36 percent of typhoid cases and deaths.

Pakistan is currently leading the way on this front. It is the first country in the world to offer a routine immunization for the typhoid. Last year, millions of children were administered the vaccine, and health experts argue that more nations must follow suit.

Antibiotic resistance is one of the world''s leading causes of death, claiming the lives of more people than HIV/AIDS or malaria. Immunes are, wherever available, some of the finest tools we can take to prevent future catastrophe.

We don''t have time to waste.

The Lancet Microbe has produced this paper.

You may also like: